Abridge Raises $30M Series B Funding Led by Spark Capital


Abridge, a leader in generative AI for clinical documentation, has successfully raised $30 million in a Series B funding round led by Spark Capital. The round also included participation from existing investor Bessemer Venture Partners and leading healthcare innovators such as CVS Health Ventures, Kaiser Permanente Ventures, Mayo Clinic, and others.

Abridge’s innovative software automatically transforms patient-clinician conversations into structured clinical notes in real-time. This solution has proven to save clinicians over two hours per day, reducing administrative burden and improving work-life balance.

In recent implementations, Abridge’s AI technology successfully drafted over 91% of clinical notes across more than 40 specialties, requiring minimal input from clinicians. The company’s platform is designed with trust and auditability in mind, allowing clinicians to quickly access source data from any AI-generated summary.

Abridge has also partnered with Epic, becoming the first Pal in Epic’s “Partners and Pals” program. This integration enables seamless integration of real-time, structured summaries of patient conversations into Epic’s clinical workflows, with successful deployments in leading healthcare institutions such as The University of Kansas Health System, UPMC, and Emory Healthcare.

The new funding will support large-scale health system rollouts and accelerate product advancements, aiming to create additional value for patients, clinicians, and health systems.

The investment marks a significant milestone for Abridge, allowing the company to further address the critical issue of clinician burnout by enabling healthcare professionals to focus more on patient care.

Related Stories